BioCentury

7:00 AM GMT, Jul 21, 2014
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

AMT-021: Interim Phase I data

Interim data from an open-label, dose-ranging, Spanish Phase I trial in 8 patients with severe acute intermittent porphyria showed that

Read the full 209 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.